Convergent Validity of DABQ Questionnaire (DABQ)

August 7, 2024 updated by: University Ghent

Convergent Validity of the DABQ Questionnaire With the Actigraph as Reference Method to Assess 24-hour Movement Behaviors Among Adults

Time-use epidemiology is a rapidly growing research area that aims to understand how individuals allocate their time to various activities throughout the day. Accurate assessment of daily activity behaviors, such as sleep, sedentary behavior (SB), light physical activity (LPA), and moderate to vigorous physical activity (MVPA), is crucial for studying the associations between activity patterns and health outcomes. To gather this information, researchers often rely on self-report questionnaires and objective measures, such as accelerometers, to provide a comprehensive understanding of individuals' activity levels.

Recently, a validated questionnaire known as the Daily Activity Behavior Questionnaire (DABQ) has been developed. In a study comparing DABQ estimates with the activPAL4 accelerometer (as the reference method), good results regarding absolute agreement and consistency were obtained for sleep duration (ICC 0.6), while the absolute agreement and consistency for SB, LPA, and MVPA estimates was lower (ICC ranging from 0.22-0.47).

It should be noted that this study acknowledges the limitation of not treating the data as compositional data. Compositional data analysis accounts for the relative distribution of different activities and avoids the assumption of independence between behaviors. Additionally, the activPAL4 accelerometer used as the reference method in the study had its own strengths and weaknesses when compared to other objective measures, such as the Actigraph. Where ActivPAL4 is more used to differentiate between sitting and standing, Actigraph is able to better classify activity intensities. Moreover, as recommended in different research, I use the Actigraph in my PhD to objectively asses 24-hour movement behaviors.

Given these considerations, the aim of this study is to validate the DABQ against the Actigraph as the reference method. Furthermore, this study aims to analyze the data as compositional data, which would provide a more comprehensive understanding of the interrelatedness of behaviors. The hypothesis is that there will be moderate convergent validity between the DABQ and Actigraph, allowing for accurate assessment of sleep duration, SB, LPA, and MVPA. By establishing the validity of the DABQ and considering the data as compositional, researchers can utilize this questionnaire in time-use epidemiology studies, which could be seen as an easy to use and cost-effective measurement method.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Belgium
      • Ghent, Belgium, 9000
        • Ghent University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

- Adults between 18 and 65 years old

Exclusion Criteria:

  • Physical (e.g. amputations, paralysis, recovering from stroke, osteoarthritis conditions that obstruct daily functioning
  • Cognitive (e.g. dementia, psychological disorders) conditions that obstruct daily functioning
  • Major medical (e.g. Chronic respiratory diseases, heart failure, cardiovascular diseases) conditions that obstruct daily functioning

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Adults

In this study, participants will have one contact session with the researcher, which will be held either at Ghent University Hospital or at the participants' home. During this session, participants will be provided with an accelerometer device and two questionnaires (to be filled in after wearing the Actigraph), namely the Daily Activity Behavior Questionnaire (DABQ) and general information questionnaire.

The participants will receive an Actigraph wGT3X+BT accelerometer which will be worn for seven consecutive days. Instructions will be given on how to wear the accelerometer (e.g. during the day at the hip and during the night at the wrist). At the end of this week, the participants will fill in both questionnaires. After wearing the accelerometer for seven consecutive days and filling in both questionnaires, the researcher will visit the participants to collect the devices, or the participants will send them back by postal package.
Device: DABQ questionnaire versus Actigraph as reference method

In this study, participants will have one contact session with the researcher, which will be held either at Ghent University Hospital or at the participants' home. During this session, participants will be provided with an accelerometer device and two questionnaires (to be filled in after wearing the Actigraph), namely the Daily Activity Behavior Questionnaire (DABQ) and general information questionnaire.

The participants will receive an Actigraph wGT3X+BT accelerometer which will be worn for seven consecutive days. Instructions will be given on how to wear the accelerometer (e.g. during the day at the hip and during the night at the wrist). At the end of this week, the participants will fill in both questionnaires. After wearing the accelerometer for seven consecutive days and filling in both questionnaires, the researcher will visit the participants to collect the devices, or the participants will send them back by postal package.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total 24-hour movement behaviors collected by the Actigraph GT3X+BT
Time Frame: Through study completion, an average of 2 weeks
The Actigraph GT3X+BT will objectively collect time spent in sleep, sedentary behavior and physical activity. This device will be worn be the participants during 7 consecutive days (at night at their non-dominant wrist and during the day at their right hip).
Through study completion, an average of 2 weeks
Total 24-hour movement behaviors collected by the Daily Activity Behavior Questionnaire (DABQ)
Time Frame: Through study completion, an average of 2 weeks
This questionnaire will subjectively collect time spent in sleep, sedentary behavior and physical activity. This questionnaire will be filled in at the end of the 7 days wearing the Actigraph mentioned in outcome 1.
Through study completion, an average of 2 weeks
Convergent validity between time spent in 24-hour movement behaviors collected by the Actigraph GT3X+BT and DABQ
Time Frame: Through study completion, an average of 2 weeks
Intraclass correlation coefficient (95% confidence intervals) and pearson/spearman correlation will be used to measure the convergent validity and intermeasurement reliability. This method allows the comparison between self-reported use of time and the device measured use of time for each behavior separately.
Through study completion, an average of 2 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Participant characteristics "sex" potentially explaining biases in reporting 24-hour movement behaviors.
Time Frame: Through study completion, an average of 2 weeks
Interaction effects between difference in measurement (Actigraph versus DABQ) and participant characteristics are explored to better interpret discrepancies between questionnaire- and accelerometer-assessed physical activity, ensuring more reliable and generalizable findings.
Through study completion, an average of 2 weeks
Participant characteristics "age" potentially explaining biases in reporting 24-hour movement behaviors.
Time Frame: Through study completion, an average of 2 weeks
Interaction effects between difference in measurement (Actigraph versus DABQ) and participant characteristics are explored to better interpret discrepancies between questionnaire- and accelerometer-assessed physical activity, ensuring more reliable and generalizable findings.
Through study completion, an average of 2 weeks
Participant characteristics "body mass index" potentially explaining biases in reporting 24-hour movement behaviors.
Time Frame: Through study completion, an average of 2 weeks
Interaction effects between difference in measurement (Actigraph versus DABQ) and participant characteristics are explored to better interpret discrepancies between questionnaire- and accelerometer-assessed physical activity, ensuring more reliable and generalizable findings.
Through study completion, an average of 2 weeks
Participant characteristics "family situation" potentially explaining biases in reporting 24-hour movement behaviors.
Time Frame: Through study completion, an average of 2 weeks
Interaction effects between difference in measurement (Actigraph versus DABQ) and participant characteristics are explored to better interpret discrepancies between questionnaire- and accelerometer-assessed physical activity, ensuring more reliable and generalizable findings.
Through study completion, an average of 2 weeks
Participant characteristics "children" potentially explaining biases in reporting 24-hour movement behaviors.
Time Frame: Through study completion, an average of 2 weeks
Interaction effects between difference in measurement (Actigraph versus DABQ) and participant characteristics are explored to better interpret discrepancies between questionnaire- and accelerometer-assessed physical activity, ensuring more reliable and generalizable findings.
Through study completion, an average of 2 weeks
Participant characteristics "educational level" potentially explaining biases in reporting 24-hour movement behaviors.
Time Frame: Through study completion, an average of 2 weeks
Interaction effects between difference in measurement (Actigraph versus DABQ) and participant characteristics are explored to better interpret discrepancies between questionnaire- and accelerometer-assessed physical activity, ensuring more reliable and generalizable findings.
Through study completion, an average of 2 weeks
Participant characteristics "sedentary job" potentially explaining biases in reporting 24-hour movement behaviors.
Time Frame: Through study completion, an average of 2 weeks
Interaction effects between difference in measurement (Actigraph versus DABQ) and participant characteristics are explored to better interpret discrepancies between questionnaire- and accelerometer-assessed physical activity, ensuring more reliable and generalizable findings.
Through study completion, an average of 2 weeks
Participant characteristics "net family income" potentially explaining biases in reporting 24-hour movement behaviors.
Time Frame: Through study completion, an average of 2 weeks
Interaction effects between difference in measurement (Actigraph versus DABQ) and participant characteristics are explored to better interpret discrepancies between questionnaire- and accelerometer-assessed physical activity, ensuring more reliable and generalizable findings.
Through study completion, an average of 2 weeks
Participant characteristics "smoking status" potentially explaining biases in reporting 24-hour movement behaviors.
Time Frame: Through study completion, an average of 2 weeks
Interaction effects between difference in measurement (Actigraph versus DABQ) and participant characteristics are explored to better interpret discrepancies between questionnaire- and accelerometer-assessed physical activity, ensuring more reliable and generalizable findings.
Through study completion, an average of 2 weeks
Participant characteristics "feasibility of wearing the Actigraph" potentially explaining biases in reporting 24-hour movement behaviors.
Time Frame: Through study completion, an average of 2 weeks
Interaction effects between difference in measurement (Actigraph versus DABQ) and participant characteristics are explored to better interpret discrepancies between questionnaire- and accelerometer-assessed physical activity, ensuring more reliable and generalizable findings.
Through study completion, an average of 2 weeks
Participant characteristics "annoying to wear the Actigraph" potentially explaining biases in reporting 24-hour movement behaviors.
Time Frame: Through study completion, an average of 2 weeks
Interaction effects between difference in measurement (Actigraph versus DABQ) and participant characteristics are explored to better interpret discrepancies between questionnaire- and accelerometer-assessed physical activity, ensuring more reliable and generalizable findings.
Through study completion, an average of 2 weeks
Participant characteristics "consistency of wearing the Actigraph" potentially explaining biases in reporting 24-hour movement behaviors.
Time Frame: Through study completion, an average of 2 weeks
Interaction effects between difference in measurement (Actigraph versus DABQ) and participant characteristics are explored to better interpret discrepancies between questionnaire- and accelerometer-assessed physical activity, ensuring more reliable and generalizable findings.
Through study completion, an average of 2 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Ghent

Investigators

  • Principal Investigator: Marieke De Craemer, University Ghent

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 30, 2023

Primary Completion (Actual)

July 1, 2024

Study Completion (Actual)

July 1, 2024

Study Registration Dates

First Submitted

February 26, 2024

First Submitted That Met QC Criteria

June 17, 2024

First Posted (Actual)

June 20, 2024

Study Record Updates

Last Update Posted (Actual)

August 9, 2024

Last Update Submitted That Met QC Criteria

August 7, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • ONZ-2023-0384

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Health Behavior

Clinical Trials on DABQ questionnaire versus Actigraph as reference method

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kazakhstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe